Liso-cel cost-effective for second-line relapsed/refractory lymphoma
Lisocabtagene maraleucel (liso-cel), a chimeric antigen receptor (CAR) T-cell remedy, is cost-effective for second-line diffuse giant B-cell lymphoma (DLBCL) remedy, ...
Tag: costeffective
Prostate cancer focal therapy is cost-effective and may improve patient outcomes
Credit score: Los Muertos Crew from Pexels Minimally invasive focal therapies for prostate most cancers are related to a decrease ...